<code id='636673BB0F'></code><style id='636673BB0F'></style>
    • <acronym id='636673BB0F'></acronym>
      <center id='636673BB0F'><center id='636673BB0F'><tfoot id='636673BB0F'></tfoot></center><abbr id='636673BB0F'><dir id='636673BB0F'><tfoot id='636673BB0F'></tfoot><noframes id='636673BB0F'>

    • <optgroup id='636673BB0F'><strike id='636673BB0F'><sup id='636673BB0F'></sup></strike><code id='636673BB0F'></code></optgroup>
        1. <b id='636673BB0F'><label id='636673BB0F'><select id='636673BB0F'><dt id='636673BB0F'><span id='636673BB0F'></span></dt></select></label></b><u id='636673BB0F'></u>
          <i id='636673BB0F'><strike id='636673BB0F'><tt id='636673BB0F'><pre id='636673BB0F'></pre></tt></strike></i>

          hotspot

          hotspot

          author:hotspot    Page View:6765
          An artist's rendering of the building — currently under construction along Boston's Fort Point Channel — where Eli Lilly plans to open its Institute for Genetic Medicine. Courtesy Alexandria Real Estate Equities Inc

          Eli Lilly and Co., which transformed itself from a stodgy underperformer into one of the world’s hottest pharmaceutical companies, said this week that the genetic medicine research center it plans to open in Boston in August will eventually employ twice as many workers as originally estimated.

          In February 2022, Lilly said that it would increase its modest Massachusetts workforce from 120 to 250 employees when it opened the $700 million Lilly Institute for Genetic Medicine along Fort Point Channel. The Indianapolis-based company said it would move 120 scientists from Kendall Square in Cambridge to the institute and add another 130.

          advertisement

          But Daniel Skovronsky, Lilly’s chief scientific and medical officer, said in an interview that the 12-story, 334,000-square-foot laboratory and office building will ultimately accommodate 500 Lilly scientists and researchers.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Medicare Advantage enrollment grows 7.1% to 33.4 million people
          Medicare Advantage enrollment grows 7.1% to 33.4 million people

          PabloMartinezMonsivais/APRoughly33.4millionadultsolderthan65andpeoplewithdisabilitieswereenrolledina

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          FDA warns medical device makers about rise in fabricated data

          ManuelBalceCeneta/APAnincreasingnumberofmedicaldevicecompaniesaresubmittingfabricatedandunreliableda